Globus Medical Inc (NYSE:GMED)
$ 74.29 0.09 (0.12%) Market Cap: 10.06 Bil Enterprise Value: 10.08 Bil PE Ratio: 247.63 PB Ratio: 2.53 GF Score: 97/100

Q3 2021 Globus Medical Inc Earnings Call Transcript

Nov 04, 2021 / 08:30PM GMT
Release Date Price: $77.35 (-1.12%)
Operator

Welcome to the Globus Medical's Third Quarter 2021 Earnings Call. (Operator Instructions) I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead.

Brian J. Kearns
Globus Medical, Inc. - SVP of Business Development & IR

Thank you, Amanda, and thank you, everyone, for being with us today. Joining today's call from Globus Medical will be Dave Demski, President and CEO; Dan Scavilla, Executive Vice President, Chief Commercial Officer; and Keith Pfeil, Senior Vice President and Chief Financial Officer.

This review is being made available via webcast accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com. Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2020 fiscal year and our subsequent filings with the Securities and Exchange

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot